Inventor profile of:

David Ayares

City:

Blacksburg, Virginia

Country:

United States

Published Applications:

15

Last publication date:

2026-06-18

Top Assignees for applications by David Ayares

The entities that hold a legal rights for patent applications filed by inventor Ayares David:

Recent patent applications by Ayares David

David Ayares from Blacksburg, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18
US20260166199A1
Human necessities

GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF

#2 | 2022-08-18
US20220257829A1
Human necessities

COMPOSITIONS AND METHODS FOR PREVENTING ALLERGIES

#3 | 2022-07-07
US20220211018A1
Human necessities

MULTI-TRANSGENIC PIGS WITH GROWTH HORMONE RECEPTOR KNOCKOUT FOR XENOTRANSPLANTATION

#4 | 2022-03-10
US20220072200A1
Human necessities

GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF

#5 | 2020-04-09
US20200109415A1
Chemistry; metallurgy

Ungulates with genetically modified immune systems

#6 | 2019-04-18
US20190111180A1
Human necessities

Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase

#7 | 2017-06-29
US20170183685A1
Chemistry; metallurgy

Ungulates with Genetically Modified Immune Systems

#8 | 2015-07-02
US20150182664A1
Human necessities

Tissue products derived from animals lacking any expression of functional alpha 1, 3 galactosyltransferase

#9 | 2014-01-16
US20140017215A1
Human necessities

Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof

#10 | 2012-11-08
US20120282226A1
Human necessities

Tissue Products Derived From Animals Lacking Any Expression of Functional Alpha 1, 3 Galactosyltransferase

#11 | 2011-02-17
US20110038841A1
Human necessities

Multi-transgenic pigs for diabetes treatment

#12 | 2010-03-25
US20100077494A1
Chemistry; metallurgy

Ungulates with genetically modified immune systems

#13 | 2008-01-31
US20080026457A1
Chemistry; metallurgy

Ungulates with genetically modified immune systems

#14 | 2006-06-15
US20060130157A1
Human necessities

Ungulates with genetically modified immune systems

#15 | 2005-11-24
US20050260176A1
Human necessities

Tissue products derived from porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase

InventorID:

613595 ⎘